HCV - Liver Fibrosis
Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C - 7/04/08Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C - 6/24/08 Non-invasive Markers for Liver Fibrosis in Hepatitis C Patients with Normal ALT - 3/11/08Insulin Resistance is a Risk Factor for Liver Fibrosis Even without Steatosis - 2/29/08 Genetic Variations in HCV Genotype 3 Core Protein Promote Liver Fat Accumulation - 2/26/08 Non-Invasive Ways to Assess Liver Disease: Studies Test Alternatives to Liver Biopsy - 2/05/08 Frequent Cannabis Use is Associated with Liver Fibrosis Progression in Hepatitis C Patients - 1/25/08 Use of CT Scans to Monitor Liver Fibrosis in People with Hepatitis C - 1/14/08 Non-invasive FibroTest and FibroScan Predict Liver Cirrhosis Better than Earlier Stages of Fibrosis in Hepatitis C Patients - 12/11/07Liver Stiffness Measurement (FibroScan) More Useful for Assessing Fibrosis in Patients with HCV Compared with HBV- 12/04/07 Natural History of Hepatitis C in Patients with Severe Liver Fibrosis - 7/10/07FIB-4: An Inexpensive and Accurate Marker of Liver Fibrosis in Patients with Hepatitis C - 7/03/07Comparison of 6 Non-invasive Measures for Diagnosing Liver Fibrosis in Hepatitis C Patients - 6/19/07 Response to PegIntron/ribavirin Leads to Stabilization of Fibrosis in Liver Transplant Recipients - 5/01/07
Antiretroviral Therapy Reduces Liver Fibrosis Progression in HIV-HCV Coinfected Patients - 3/20/07
FDA-approved Combination Therapies for Chronic HCV Infection
Pegasys + Copegus PEG-Intron + Rebetol Intron A + Rebetol Roferon A + Ribavirin Treatment Guidelines
HCV Articles by Topic
HCV Liver Issues Cirrhosis Fibrosis Hepatocellular Carcinoma Liver Transplantation Liver Biopsy Steatosis